UPDATE 1-FDA approves generic version of Jazz Pharma's sleep disorder drug

Jan 17 (Reuters) - The U.S. Food and Drug Administration

said it had approved the first generic version of Xyrem, Jazz

Pharmaceuticals Plc's drug to treat patients with

narcolepsy, a kind of sleeping...

Read more